
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism
Zhen Zhang, Jianjun Li, Yang Ou, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 62
Zhen Zhang, Jianjun Li, Yang Ou, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 62
Showing 51-75 of 62 citing articles:
Interaction of TAGLN and USP1 promotes ZEB1 ubiquitination degradation in UV-induced skin photoaging
Yinan Li, Xiu Huang, Jing Jin, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Yinan Li, Xiu Huang, Jing Jin, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Knockdown of ZEB1 Inhibits Hypertrophic Scarring through Suppressing the Wnt/β-catenin Signaling Pathway in a Mouse Model
Rui Jin, Zhizhong Deng, Fei Liu, et al.
Plastic & Reconstructive Surgery (2023) Vol. 154, Iss. 5, pp. 991-1001
Open Access | Times Cited: 2
Rui Jin, Zhizhong Deng, Fei Liu, et al.
Plastic & Reconstructive Surgery (2023) Vol. 154, Iss. 5, pp. 991-1001
Open Access | Times Cited: 2
Correction to: CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism
Zhen Zhang, Jianjun Li, Yang Ou, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Zhen Zhang, Jianjun Li, Yang Ou, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Antitumor Activity of Eribulin After Fulvestrant Plus CDK4/6 Inhibitor in Breast Cancer Patient-derived Xenograft Models
Yuki Niwa, Makoto Asano, Takayuki Nakagawa, et al.
Anticancer Research (2020) Vol. 40, Iss. 12, pp. 6699-6712
Open Access | Times Cited: 4
Yuki Niwa, Makoto Asano, Takayuki Nakagawa, et al.
Anticancer Research (2020) Vol. 40, Iss. 12, pp. 6699-6712
Open Access | Times Cited: 4
Perfluorooctane sulfonate (PFOS) triggers migration and invasion of esophageal squamous cell carcinoma cells via regulation of Zeb1
Yaqing Liu, Jian Li, Hui Ding, et al.
Drug and Chemical Toxicology (2021) Vol. 45, Iss. 6, pp. 2804-2813
Closed Access | Times Cited: 4
Yaqing Liu, Jian Li, Hui Ding, et al.
Drug and Chemical Toxicology (2021) Vol. 45, Iss. 6, pp. 2804-2813
Closed Access | Times Cited: 4
The effect of ribociclib on the expression levels of miR-141 and CDK4/6-USP51 signaling pathway genes in MCF-7 and MDA-MB-231 cells
Shayeste Sadat Baghermanesh, Mahmood Barati, Arshad Hosseini
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0309289-e0309289
Open Access
Shayeste Sadat Baghermanesh, Mahmood Barati, Arshad Hosseini
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0309289-e0309289
Open Access
Enhancing Radiosensitivity in Osteosarcoma via CDKN2C Overexpression: A Mechanism Involving G1 Phase Arrest Mediated by Inhibition of CDK4 Expression and Thr172 Phosphorylation
Qiujian Lian, Haonan Zhao, Bingxuan Wang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 735, pp. 150840-150840
Open Access
Qiujian Lian, Haonan Zhao, Bingxuan Wang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 735, pp. 150840-150840
Open Access
Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple‐Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1‐Regulated Cholesterol Metabolism
Yilan Yang, Jiatao Liao, Zhe Pan, et al.
Advanced Science (2024)
Open Access
Yilan Yang, Jiatao Liao, Zhe Pan, et al.
Advanced Science (2024)
Open Access
Risk of secondary tumours in patients with non-metastatic and metastatic human retinoblastoma
Reza Sadeghi, Hanieh Pirankuraim, Shamim Taghvaei Javanshir, et al.
Eye (2022) Vol. 37, Iss. 11, pp. 2327-2334
Closed Access | Times Cited: 1
Reza Sadeghi, Hanieh Pirankuraim, Shamim Taghvaei Javanshir, et al.
Eye (2022) Vol. 37, Iss. 11, pp. 2327-2334
Closed Access | Times Cited: 1
In Vivo CRISPR Screens Identify RhoV as a Pro-Metastasis Factor of Triple-Negative Breast Cancer
Zhi‐Ming Shao, Ming‐Liang Jin, Yue Gong, et al.
Research Square (Research Square) (2022)
Open Access
Zhi‐Ming Shao, Ming‐Liang Jin, Yue Gong, et al.
Research Square (Research Square) (2022)
Open Access
Role of pre-metastatic niche in organ specificity of breast cancer metastasis. Influence on metastatic potential as a basis for CDK4/6-inhibition efficacy in early therapy of disseminated hormone-receptor-positive disease
А. I. Stukan, А. Yu. Goryainova, Е. V. Lymar, et al.
Meditsinskiy sovet = Medical Council (2021), Iss. 20, pp. 25-34
Open Access
А. I. Stukan, А. Yu. Goryainova, Е. V. Lymar, et al.
Meditsinskiy sovet = Medical Council (2021), Iss. 20, pp. 25-34
Open Access